Industry
[Bio USA] Samsung Biologics seeks giant leap with new plant, ADC tech
June 6, 2023
BOSTON, Massachusetts -- South Korean biologics contract manufacturer Samsung Biologics will make another huge step forward by shortening the construction time for its new manufacturing facility with an annual production capacity of 180,000 liters by five months to meet the growing demand from its clients in the pharmaceutical industry, the firm’s CEO, John Rim, said Monday. The Korean firm has now secured as clients 13 of the top 20 global pharmaceutical companies, including GlaxoSmit